Inventor · disambiguated record
Shouhua Xiao
Also filed as: XIAO SHOUHUA
10 granted patents·3 pending applications·28 citations·filing 2014–2024
85Inventor score
Top patents by PatentIndex Score
13 records- 0194US9765157B2Antibody constructs for CDH19 and CD3AMGEN INC·Filed 2015·Granted Sep 19, 2017·13 cites·14 claims
- 0287US10059766B2Antibody constructs for CDH19 and CD3AMGEN RES MUNICH GMBH·Filed 2014·Granted Aug 28, 2018·9 cites·17 claims
- 0382US12297292B2Antibody constructs for CDH19 and CD3AMGEN INC·Filed 2017·Granted May 13, 2025·2 cites·12 claims
- 0481US11053311B2Antibodies targeting CDH19 for melanomaAMGEN INC·Filed 2018·Granted Jul 6, 2021·1 cites·25 claims
- 0581US2025084160A1Antibodies targeting cdh19 for melanomaAMGEN INC·Filed 2024·Application pending·0 cites
- 0679US11498964B2Antibody constructs for CDH19 and CD3AMGEN RES MUNICH GMBH·Filed 2018·Granted Nov 15, 2022·1 cites·17 claims
- 0778US12441796B2Antibody constructs for CDH19 and CD3AMGEN INC·Filed 2022·Granted Oct 14, 2025·0 cites·17 claims
- 0871US12365732B2Anti-CD96 antibodies and methods of use thereof23ANDME INC·Filed 2022·Granted Jul 22, 2025·0 cites·24 claims
- 0970US11325982B2Biparatopic and multiparatopic antibodies with common light chain and method of useXUANZHU BIOPHARMACEUTICAL CO LTD·Filed 2018·Granted May 10, 2022·1 cites·18 claims
- 1070US9920121B2Antibodies targeting CDH19 for melanomaAMGEN INC·Filed 2014·Granted Mar 20, 2018·1 cites·25 claims
- 1170US2022127354A1Antibodies targeting cdh19 for melanomaAMGEN INC·Filed 2021·Application pending·0 cites
- 1264US11555073B2Anti-CD96 antibodies and methods of use thereof23ANDME INC·Filed 2019·Granted Jan 17, 2023·0 cites·28 claims
- 1362US2020071405A1Antibody constructs for cdh19 and cd3AMGEN RES MUNICH GMBH·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Shouhua Xiao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →